Key result
Chymase inhibitors prevent vascular proliferation and intimal hyperplasia in injured vessels, outperforming ACE inhibitors.
Why the study?
In vascular tissues, angiotensin II is cleaved from angiotensin I by both ACE and chymase, which is activated upon release from mast cells after local vessel injury such as grafting or balloon catheterization.
Do chymase inhibitors prevent vascular proliferation and intimal hyperplasia in injured vessels without affecting blood pressure?
Do chymase inhibitors prevent vascular proliferation and intimal hyperplasia in injured vessels without affecting blood pressure?
Chymase inhibitors suppress local angiotensin II production and intimal hyperplasia following vascular injury without lowering systemic blood pressure, representing a potential therapeutic strategy against vascular disorders and restenosis.
Answers are grounded in this paper and cite their sources.
May offer BP-independent target against restenosis; leaves open translation to human trials.
In vascular tissues, angiotensin II is potentially cleaved from angiotensin I by chymase and angiotensin converting enzyme (ACE). In the normal state, ACE regulates angiotensin II formation and plays a crucial role in the regulation of blood pressure, whereas chymase is stored in mast cells and has no angiotensin II-forming activity. Chymase is activated immediately upon its release into the extracellular matrix in vascular tissues after mast cells have been activated by local stimuli such as vessel injury by grafting or a balloon catheter. In dog grafted veins, vascular proliferation, chymase activity, angiotensin II concentration and mRNA levels of fibronectin, collagen I and collagen III were significantly increased after the operation, while they were significantly suppressed by a chymase inhibitor. A clinical trial of an angiotensin II receptor blocker (ARB) for preventing restenosis after percutaneous transluminal coronary angioplasty was successful, but that of an ACE inhibitor was not. After balloon injury in dog vessels, chymase activity was signifcantly increased in the injured artery, and a chymase inhibitor and an ARB were effective in preventing the vascular proliferation, but an ACE inhibitor was ineffective. On the other hand, a chymase inhibitor, unlike an ACE inhibitor and an ARB, did not affect blood pressure. These reports indicate that local angiotensin II production by chymase is involved only in the intimal hyperplasia seen in the injured vessels. Therefore, chymase inhibitors may be useful for preventing vascular disoders without affecting blood pressure.
No takes yet. Share an insight, caveat, or question.
Takai et al. (2003) conducted a review in Vascular injury and intimal hyperplasia. Chymase inhibitor vs. Angiotensin-converting enzyme (ACE) inhibitor and angiotensin II receptor blocker (ARB) was evaluated on Vascular proliferation and intimal hyperplasia in injured vessels. Chymase inhibitors prevented vascular proliferation and intimal hyperplasia in injured dog vessels without affecting blood pressure, whereas ACE inhibitors were ineffective.
Synapse has enriched 10 related papers. Consider them for comparative context: